Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients with Acute Heart Failure, Congestion, and Worsening Renal Function

Takeshi Kitai, Justin L. Grodin, Yong Hyun Kim, W. H.Wilson Tang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background - The relationship between changes in serum sodium with clinical events in acute heart failure patients using different decongestive events has not been investigated. This study aimed to describe changes in serum sodium levels during decongestion therapy in patients receiving stepped pharmacological therapy versus ultrafiltration. Methods and Results - We studied 188 patients who were enrolled in the CARRESS-HF trial (Cardiorenal Rescue Study in Acute Decompensated Heart Failure). Treatment-induced hyponatremia was defined as admission normonatremia (≥135 mEq/L) with a subsequent decrease (<135 mEq/L) during hospitalization. Patients treated with ultrafiltration had significantly lower sodium levels than those with conventional treatment at days 1, 4, and 7 (all P<0.01), whereas those at day 30 were similar between the groups. Changes in sodium levels in patients with ultrafiltration were negatively correlated to those in serum creatinine and plasma renin activity. The incidence of treatment-induced hyponatremia was significantly higher in the ultrafiltration group than those receiving conventional treatment (P=0.002). Although patients with discharge hyponatremia had a higher risk for composite end point of all-cause death, rehospitalization, or unscheduled hospital visit in comparison to those without (adjusted hazard ratio, 1.66; 95% confidence interval, 1.03-2.65; P=0.037), the risk was comparable between patients with treatment-induced hyponatremia and those who did not experience any hyponatremia (adjusted hazard ratio, 0.93; 95% confidence interval, 0.57-1.51; P=0.76). Conclusions - Fluid removal by ultrafiltration was associated with a decrease in serum sodium levels compared with diuretic treatment but returned to baseline levels at day 30. Discharge hyponatremia but not treatment-induced hyponatremia was associated with worse clinical outcomes. Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT00608491.

Original languageEnglish (US)
Article numbere003603
JournalCirculation: Heart Failure
Volume10
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Ultrafiltration
Hyponatremia
Homeostasis
Heart Failure
Sodium
Kidney
Serum
Therapeutics
Confidence Intervals
Patient Discharge
Diuretics
Renin
Cause of Death
Creatinine
Hospitalization
Clinical Trials
Pharmacology
Incidence

Keywords

  • creatinine
  • diuretics
  • heart failure
  • hyponatremia
  • ultrafiltration

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients with Acute Heart Failure, Congestion, and Worsening Renal Function. / Kitai, Takeshi; Grodin, Justin L.; Kim, Yong Hyun; Tang, W. H.Wilson.

In: Circulation: Heart Failure, Vol. 10, No. 2, e003603, 01.02.2017.

Research output: Contribution to journalArticle

@article{4f0e4eb5edd64270ac134dba7080d5db,
title = "Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients with Acute Heart Failure, Congestion, and Worsening Renal Function",
abstract = "Background - The relationship between changes in serum sodium with clinical events in acute heart failure patients using different decongestive events has not been investigated. This study aimed to describe changes in serum sodium levels during decongestion therapy in patients receiving stepped pharmacological therapy versus ultrafiltration. Methods and Results - We studied 188 patients who were enrolled in the CARRESS-HF trial (Cardiorenal Rescue Study in Acute Decompensated Heart Failure). Treatment-induced hyponatremia was defined as admission normonatremia (≥135 mEq/L) with a subsequent decrease (<135 mEq/L) during hospitalization. Patients treated with ultrafiltration had significantly lower sodium levels than those with conventional treatment at days 1, 4, and 7 (all P<0.01), whereas those at day 30 were similar between the groups. Changes in sodium levels in patients with ultrafiltration were negatively correlated to those in serum creatinine and plasma renin activity. The incidence of treatment-induced hyponatremia was significantly higher in the ultrafiltration group than those receiving conventional treatment (P=0.002). Although patients with discharge hyponatremia had a higher risk for composite end point of all-cause death, rehospitalization, or unscheduled hospital visit in comparison to those without (adjusted hazard ratio, 1.66; 95{\%} confidence interval, 1.03-2.65; P=0.037), the risk was comparable between patients with treatment-induced hyponatremia and those who did not experience any hyponatremia (adjusted hazard ratio, 0.93; 95{\%} confidence interval, 0.57-1.51; P=0.76). Conclusions - Fluid removal by ultrafiltration was associated with a decrease in serum sodium levels compared with diuretic treatment but returned to baseline levels at day 30. Discharge hyponatremia but not treatment-induced hyponatremia was associated with worse clinical outcomes. Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT00608491.",
keywords = "creatinine, diuretics, heart failure, hyponatremia, ultrafiltration",
author = "Takeshi Kitai and Grodin, {Justin L.} and Kim, {Yong Hyun} and Tang, {W. H.Wilson}",
year = "2017",
month = "2",
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.116.003603",
language = "English (US)",
volume = "10",
journal = "Circulation. Heart failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients with Acute Heart Failure, Congestion, and Worsening Renal Function

AU - Kitai, Takeshi

AU - Grodin, Justin L.

AU - Kim, Yong Hyun

AU - Tang, W. H.Wilson

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background - The relationship between changes in serum sodium with clinical events in acute heart failure patients using different decongestive events has not been investigated. This study aimed to describe changes in serum sodium levels during decongestion therapy in patients receiving stepped pharmacological therapy versus ultrafiltration. Methods and Results - We studied 188 patients who were enrolled in the CARRESS-HF trial (Cardiorenal Rescue Study in Acute Decompensated Heart Failure). Treatment-induced hyponatremia was defined as admission normonatremia (≥135 mEq/L) with a subsequent decrease (<135 mEq/L) during hospitalization. Patients treated with ultrafiltration had significantly lower sodium levels than those with conventional treatment at days 1, 4, and 7 (all P<0.01), whereas those at day 30 were similar between the groups. Changes in sodium levels in patients with ultrafiltration were negatively correlated to those in serum creatinine and plasma renin activity. The incidence of treatment-induced hyponatremia was significantly higher in the ultrafiltration group than those receiving conventional treatment (P=0.002). Although patients with discharge hyponatremia had a higher risk for composite end point of all-cause death, rehospitalization, or unscheduled hospital visit in comparison to those without (adjusted hazard ratio, 1.66; 95% confidence interval, 1.03-2.65; P=0.037), the risk was comparable between patients with treatment-induced hyponatremia and those who did not experience any hyponatremia (adjusted hazard ratio, 0.93; 95% confidence interval, 0.57-1.51; P=0.76). Conclusions - Fluid removal by ultrafiltration was associated with a decrease in serum sodium levels compared with diuretic treatment but returned to baseline levels at day 30. Discharge hyponatremia but not treatment-induced hyponatremia was associated with worse clinical outcomes. Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT00608491.

AB - Background - The relationship between changes in serum sodium with clinical events in acute heart failure patients using different decongestive events has not been investigated. This study aimed to describe changes in serum sodium levels during decongestion therapy in patients receiving stepped pharmacological therapy versus ultrafiltration. Methods and Results - We studied 188 patients who were enrolled in the CARRESS-HF trial (Cardiorenal Rescue Study in Acute Decompensated Heart Failure). Treatment-induced hyponatremia was defined as admission normonatremia (≥135 mEq/L) with a subsequent decrease (<135 mEq/L) during hospitalization. Patients treated with ultrafiltration had significantly lower sodium levels than those with conventional treatment at days 1, 4, and 7 (all P<0.01), whereas those at day 30 were similar between the groups. Changes in sodium levels in patients with ultrafiltration were negatively correlated to those in serum creatinine and plasma renin activity. The incidence of treatment-induced hyponatremia was significantly higher in the ultrafiltration group than those receiving conventional treatment (P=0.002). Although patients with discharge hyponatremia had a higher risk for composite end point of all-cause death, rehospitalization, or unscheduled hospital visit in comparison to those without (adjusted hazard ratio, 1.66; 95% confidence interval, 1.03-2.65; P=0.037), the risk was comparable between patients with treatment-induced hyponatremia and those who did not experience any hyponatremia (adjusted hazard ratio, 0.93; 95% confidence interval, 0.57-1.51; P=0.76). Conclusions - Fluid removal by ultrafiltration was associated with a decrease in serum sodium levels compared with diuretic treatment but returned to baseline levels at day 30. Discharge hyponatremia but not treatment-induced hyponatremia was associated with worse clinical outcomes. Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT00608491.

KW - creatinine

KW - diuretics

KW - heart failure

KW - hyponatremia

KW - ultrafiltration

UR - http://www.scopus.com/inward/record.url?scp=85013488812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013488812&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.116.003603

DO - 10.1161/CIRCHEARTFAILURE.116.003603

M3 - Article

C2 - 28130379

AN - SCOPUS:85013488812

VL - 10

JO - Circulation. Heart failure

JF - Circulation. Heart failure

SN - 1941-3297

IS - 2

M1 - e003603

ER -